- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Tzu-Yun Wang
Total 453 results
-
Zhen Jun WangRecruitingGastroesophageal Reflux Disease | Sleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Angle of HisChina
-
Zhen Jun WangUnknownSleeve Gastrectomy | Excessive Weight Loss | Total Weight Loss | Jejunojejunal Bypass | UncutChina
-
Zhen Jun WangCompleted
-
Tzu-Yun WangMinistry of Science and Technology, TaiwanCompletedStimulants Use DisorderTaiwan
-
Si-Yu WangCompleted
-
Si-Yu WangCompleted
-
WANG Yan-binUnknownIschemic Postconditioning | Ischemia-reperfusion(I/R) | Cardiopulmonarybypass | the Mitochondrial PathwayChina
-
Hai-Jun WangCompletedObesity | OverweightChina
-
Hai-Jun WangCompleted
-
Nang Kuang Pharmaceutical Co., Ltd.Buddhist Tzu Chi General HospitalCompleted
-
Yue WANGEnrolling by invitationBreast Cancer FemaleChina
-
Chunxiao WangCompleted
-
wang shusenUnknown
-
wang shusenRecruiting
-
wang shusenRecruitingAdvanced HER2 Negative Breast Carcinoma HRD+Breast CancerChina
-
wang shusenRecruiting
-
wang shusenRecruiting
-
wang shusenNot yet recruitingBreast Cancer | Brain MetastasisChina
-
Xueding WangSun Yat-sen UniversityUnknownGastrointestinal Stromal Tumors | Somatic Mutation | Plasma Concentration | Germline MutationChina
-
Chunxiao WangUnknownHerpes Simplex KeratitisChina
-
Chong Kun Dang PharmaceuticalNot yet recruitingMetabolic Syndrome | Essential Hypertension
-
Chong Kun Dang PharmaceuticalNot yet recruitingCardiovascular DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalRecruitingEfficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 DiabetesType2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedAndrogenetic AlopeciaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedEndocrine, Nutritional and Metabolic DiseasesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension | DyslipidemiasKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType 2 DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertensionKorea, Republic of
-
Chong Kun Dang PharmaceuticalActive, not recruitingType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertensionKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType II Diabetes MellitusKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedChronic Heart FailureKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedChronic Hepatitis bKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypogonadismKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedType2DiabetesKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompleted
-
Chong Kun Dang PharmaceuticalCompletedType2 DiabetesKorea, Republic of